Perioperative toripalimab plus neoadjuvant chemotherapy might improve outcomes in resectable esophageal cancer: an interim analysis of a phase III randomized clinical trial

The interim results of this ongoing trial showed that in resectable ESCC, the addition of perioperative toripalimab to NAC is safe, may improve OS and might change the standard treatment in the future.

Authors

Institutions

Publication Details

Journal
Cancer Communications
Published
2024-09-02
DOI
https://doi.org/10.1002/cac2.12604
Citations
30
Primary Topic
Esophageal Cancer Research and Treatment
Type
article
Field-Weighted Citation Impact
17.18

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Perioperative toripalimab plus neoadjuvant chemotherapy might improve outcomes in resectable esophageal cancer: an interim analysis of a phase III randomized clinical trial

Peng Zhang, Zhenzhen Liu, Sining Shen, Zimin Qin et al.
30 citations
Cancer Communications
Esophageal Cancer Research and Treatment
17.18
article

Perioperative toripalimab plus neoadjuvant chemotherapy might improve outcomes in resectable esophageal cancer: an interim analysis of a phase III randomized clinical trial

Peng Zhang, Zhenzhen Liu, Sining Shen, Zimin Qin, Quanli Gao, Jie Ma, Zongfei Wang, Jinrong Qu, Zhenxuan Li, Wenqun Xing, Haoran Wang, Ming Yan, Xianben Liu, Daoyuan Wu, Haibo Sun, Qing Li, He Zhang, Peng Li, Shilei Liu, Jun Zhang, Yongkui Yu, Dongfeng Yuan, Yan Zheng, Haibo Ma, Jianping Zhu, Jiangong Zhang, Baoxing Liu, Fei Zhao, Yufeng Ba, Guanghui Liang, Wenjie Ma
article en
30 citations

Abstract

The interim results of this ongoing trial showed that in resectable ESCC, the addition of perioperative toripalimab to NAC is safe, may improve OS and might change the standard treatment in the future.

Cancer CommunicationsVol. 44(10)
Zhengzhou University (CN), Engineering Link (Canada) (CA), Henan Cancer Hospital (CN)
National Natural Science Foundation of China, Wu Jieping Medical Foundation
Good health and well-being
Openalex Percentile: Top 0%
Esophageal Cancer Research and Treatment
17.18
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.